Targeted
Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded
Nanoparticles Reverses Functional Deficits in Parkinsonian Mice
Posted on 2018-04-04 - 18:19
Excess iron deposition
in the brain often causes oxidative stress-related
damage and necrosis of dopaminergic neurons in the substantia nigra
and has been reported to be one of the major vulnerability factors
in Parkinson’s disease (PD). Iron chelation therapy using deferoxamine
(DFO) may inhibit this nigrostriatal degeneration and prevent the
progress of PD. However, DFO shows very short half-life in
vivo and hardly penetrates the blood brain barrier (BBB).
Hence, it is of great interest to develop DFO formulations for safe
and efficient intracerebral drug delivery. Herein, we report a polymeric
nanoparticle system modified with brain-targeting peptide rabies virus
glycoprotein (RVG) 29 that can intracerebrally deliver DFO. The nanoparticle
system penetrates the BBB possibly through specific receptor-mediated
endocytosis triggered by the RVG29 peptide. Administration of these
nanoparticles significantly decreased iron content and oxidative stress
levels in the substantia nigra and striatum of PD mice and effectively
reduced their dopaminergic neuron damage and as reversed their neurobehavioral
deficits, without causing any overt adverse effects in the brain or
other organs. This DFO-based nanoformulation holds great promise for
delivery of DFO into the brain and for realizing iron chelation therapy
in PD treatment.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
You, Linhao; Wang, Jing; Liu, Tianqing; Zhang, Yinlong; Han, Xuexiang; Wang, Ting; et al. (2018). Targeted
Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded
Nanoparticles Reverses Functional Deficits in Parkinsonian Mice. ACS Publications. Collection. https://doi.org/10.1021/acsnano.7b08172
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
AUTHORS (14)
LY
Linhao You
JW
Jing Wang
TL
Tianqing Liu
YZ
Yinlong Zhang
XH
Xuexiang Han
TW
Ting Wang
SG
Shanshan Guo
TD
Tianyu Dong
JX
Junchao Xu
GA
Gregory J. Anderson
QL
Qiang Liu
YC
Yan-Zhong Chang
XL
Xin Lou
GN
Guangjun Nie
KEYWORDS
dopaminergic neuron damageiron chelation therapybrain-targeting peptide rabies virus glycoproteinPDIron chelation therapyTargeted Brain DeliveryRabies Virus Glycoprotein 29- Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficitsnanoparticle systemBBBoxidative stress levelsDFOsubstantia nigrablood brain barrierRVG 29 peptideintracerebral drug delivery